BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
0.7757
-0.0326 (-4.03%)
Jul 28, 2026, 12:22 PM EDT - Market open
BioCardia Market Cap
BioCardia has a market cap or net worth of $8.82 million as of July 28, 2026. Its market cap has decreased by -31.14% in one year.
Market Cap
8.82M
Enterprise Value
8.66M
1-Year Change
-31.14%
Ranking
Category
Stock Price
$0.78
ChartMarket Cap Chart
Since October 26, 2016, BioCardia's market cap has decreased from $29.07M to $8.82M, a decrease of -69.65%. That is a compound annual growth rate of -11.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 8.82M | -33.49% |
| Dec 31, 2025 | 13.27M | 32.74% |
| Dec 31, 2024 | 9.99M | -36.30% |
| Dec 29, 2023 | 15.69M | -62.55% |
| Dec 30, 2022 | 41.90M | 28.00% |
| Dec 31, 2021 | 32.73M | -33.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoMed Therapeutics | 10.65M |
| BioVie | 10.33M |
| Chemomab Therapeutics | 10.22M |
| Lunai Bioworks | 10.11M |
| Theriva Biologics | 9.78M |
| Vistagen Therapeutics | 9.45M |
| Curis | 9.14M |
| Aspire Biopharma Holdings | 9.03M |